SaiyanMedRetatrutide
Ordered Retatrutide from SaiyanMed? Mail in a sample (US only) and let us test it for free.
Test my supplySaiyan Med Retatrutide's evidence is held back by a Nov 2025 purity miss at 98.52%, while later tests rebounded to 99.8–99.9% with identity passes. Check mixed batch documentation and modest fill deviations, not just the rebound.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including SaiyanMed rows.
Cancel anytime
Ordered Retatrutide from SaiyanMed? Mail in a sample (US only) and let us test it for free.
Test my supplyAbout SaiyanMed test results from Finnrick
SaiyanMed is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 6 peptides and 48 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible SaiyanMed peptides in this dataset are Retatrutide (24 tests) and Melanotan II (3 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 48 recent tests.
Ordered Retatrutide from SaiyanMed? Mail in a sample (US only) and let us test it for free.
Test my supply